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The aims of the study are to explore the eﬀect of ursolic acid (UA) on the growth of gastric cancer cell line BGC-803 and
hepatocellular cancer cell H22 xenograft and to understand the mechanism. UA inhibits growth of BGC-803 cells in vitro in
dose-dependent and time-dependent manner. Treated with UA in vivo, tumor cells can be arrested to G0/G1 stage. The apoptotic
ratewassigniﬁcantlyincreasedintumorcells treated withUAboth invitro andinvivo.DNAfragmentationwasfoundinBGC-803
cells exposed to UA. UA activated caspase-3, -8, and -9 and down regulated expression of Bcl-2 in BGC-803 cells. The expression
of caspase-3 and -8 was elevated in tumor cells from xenograft treated with UA. 18F-FLT PET-CT imaging conﬁrmed tumor
model and UA eﬀectiveness. Our results indicated that UA inhibits growth of tumor cells both in vitro and in vivo by decreasing
proliferation of cells and inducing apoptosis.
1.Introduction
Gastric cancer is the second cause of cancer-related death
worldwide, and it has now become the ﬁrst cancer-related
death in China. Hepatocellular carcinoma is a primary
ma-lignancy of the liver and is the third leading cause
of cancer-related death worldwide. There are about 110,000
people died of gastric cancer and hepatocellular carcinoma
in Chinaeveryyear, which accountsfor 45%(forbothcancer
combined) mortality worldwide. In addition to surgery,
radiotherapy, and chemotherapy, it is essential to ﬁnd a
more eﬀective way to treat gastric cancer and hepatocellular
carcinoma.
M o r ea n dm o r ec l i n i c a lp r a c t i c es h o w st h a tt h eC h i n e s e
medicinal herbs have antitumor activity, which sheds a light
on new therapeutic strategy for cancer treatment [1–3].
Ursolic acid (UA) is a pentacyclic triterpene compound and
exists in medicinal herbs such as Oldenlandia diﬀusa and
Radix actinidiae. UA has been shown to have the eﬀects of
anti-inﬂammatory, antioxidant, and antitumor [4–6]. Stud-
ies have found that UA can inhibit the activities of DNA
polymerase and DNA topoisomerase and decrease the rate
of cell proliferation [7]. Moreover, UA can induce apoptosis
of tumor cell by increasing the level of intracellular calcium
ion [8], suppressing the expression ofFoxM1[9], and upreg-
ulating of death receptors [10]. In this study, we evaluated
the eﬀect of UA treatment on the gastric cancer cell and the
hepatocellular carcinoma xenograft.
2.Materialsand Methods
2.1. Material. UA was purchased from Shanxi Huike Plant
Development Corporation (UR: 2003 0610 purity ≥98%).
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) and DMSO were purchased from SIGMA
Company. Annexin-V-FITC apoptosis kit was purchased
from BD Biosciences. RPMI 1640 and calf serum was pur-
chased from GIBCO, Invitorgen. All the antibodies used in2 Journal of Biomedicine and Biotechnology
western blot (rabbit antihuman β-actin, mouse antihuman
procaspase-3, mouse antihuman procaspase-8, mouse anti-
human procaspase-9, mouse antihuman Bcl-2, and mouse
antihuman Bax antibodies) were purchased from SANTA
CRUZBiotechnology.Farinfrared-marked goatantirabbitor
mouse secondary antibodies were purchased from ROCK-
LAND Immunochemicals. Odyssey far infrared scanner was
purchased from LI-COR Biosciences (USA).
2.2. Cell Lines and Culture Conditions. BGC-803 cell and he-
patocellularcarcinoma cell line H22 (ATCC, USA)were gen-
erous gifts from Dr. Yang Ke at the Cancer Research Center,
Peking University. Gastric cancer cell line BGC-803 was
maintained in RPMI-1640 with 10% calf serum. Cells were
grown at 37◦Ci naC O 2 incubator. The cells in the expo-
nential growth phase were collectedfor cell proliferation, cell
cycle, and apoptosis assay.
2.3. Mouse Model. T e nm a l ea n dt e nf e m a l ek u n m i n gm i c e
were bought from The Research Center for Laboratory
Animal Science in Beijing, and H22 cells of exponential
growth phase were injected subcutaneously into right front
axilla of kuming mice. The mice were divided into two
groups with equal numbers of male and female mice. One
group was given 0.2mL/mouse physiological saline by oral
administration as negative control; another group was given
2.53mg/mouseUAeverydayfor10days.Miceweresacriﬁced
at the end of the treatment. Tumors tissues were either ﬁxed
in 75 ethanol ﬁltered after treated by 500 mesh to get the
single cell suspension for ﬂow cytometry analysis or ﬁxed
in 4% paraformaldehyde for pathological analysis. Samples
prepared from tumor tissues were also ﬂash frozen in liquid
nitrogen for Western blot analysis. All animal experiments
were approved by Animal Care and Use Committee, Inner
Mongolia Medical College.
2.4. Cell Proliferation Assay. Cell proliferation was assessed
by MTT staining. 250μL of BGC-803 cells (1.2 × 104/mL)
were added to each well in the 96-well plate. UA was added
to the ﬁnal concentration of 10–60μM. DMSO and culture
medium were added as control. Each group was performed
in 8 wells. MTT was added 12h, 24h, 36h, and 48h,
respectively,afterincubation,andtheabsorbancevalueswere
examined. The inhibiting proliferation rates were calculated
using the following equation:
Inhibiting proliferation rate (%)
=

A values of control group − A values of treated group

A values of control group
×100%.
(1)
2.5. 18F - F L TPE T - C TI ma gi n g . Proliferationoftumorcellsin
mouse xenograft model was examined with positron-emis-
sion tomography-computed tomography (PET-CT) using
18F ﬂuoro-L-thymidine (FLT). 18F-FLT was given to the
mouse by tail intravenous injection. Mice were anesthetized
by ether and then were imaged by PET-CT.
2.6. Cell Cycle and Apoptosis Assay. BGC-803 cells were
treated with UAeither at concentration of median inhibition
concentration (IC50)( 2 4 h )f o r2 4 h ,o ra tc o n c e n t r a t i o n
of IC50 (36h) for 36h, and then cells were ﬁxed in 75%
ethanol. Tumor cells obtained from xenograft were also ﬁxed
in 75% ethanol after ﬁltered by 500 mesh. The single-cell
suspension obtained above was used for apoptosis analysis
using ﬂow cytometry and for cell cycleanalysis using ModFit
analysis. DNA was extracted from BGC-803 cells according
to protocol provided by manufacturer and then isolated
in the 1.5% agarose gel by electrophoresis (65V, 1.75h).
Photographs were takenusing a gel-imaging system to detect
DNA Ladder.
2.7. Western Blot Analysis. Expression of procaspase-3, -8,
and -9, Bcl-2, and Bax in BGC-803 treated with UA for
36h at IC50 and expression of caspase-3 and -8 in tumor
cells obtained from xenograft was determined by western
blot. Cells were treated with RIPA buﬀer (1% deoxycholate,
0.1% SDS). Concentration of protein was determined by
BCA assay. Proteins were transferred to PVDF membrane
after separation by SDS-PAGE and incubated with proper
primary and secondary antibodies. The signal was detected
byfar infraredscanner. Resultwasanalyzed byQuantityOne.
The relative amount of protein expressed was determined by
using β-actin as an internal control.
2.8. Statistical Analysis. Statistical analysis was performed
using the program SPSS13.0. In each experimental group,
one-factor analysis of variance and MANOVA of repeated
measuring were used. The t-test was used for comparison
between groups. A value of P<. 05 was considered to be
statistically signiﬁcant. IC50 values at diﬀerent time points
were calculated by Probit Analysis.
3.Results
3.1.Inhibition ofProliferationinBGC-803Cells. Proliferation
of BGC-803 cells was examined to assess whether UA had
inhibitory eﬀect on BGC-803. Cells were treated with dif-
ferent concentrations of UA (10, 20, 30, 40, 50, 60μmol/L)
for 12, 24, 36, 48h, respectively. Compared with control,
UA (20–60μmol/L) inhibited BGC-803 cell proliferation in
dose- and time-dependent manners. However, 10μmol/L of
UA did not show inhibitory eﬀect (Figure 1(a)). The IC50 of
UA at diﬀerent time points (12h, 24h, 36h and 48h) were
61.29μM, 43.78μM, 35.94μM, and 24.95μM, respectively
(Table 1).
3.2. Induction of Apoptosis in BGC-803 Cells. Morphological
changes of BGC-803 cells after UA treatment. Cells not
treated with UA showed single-layer adherence growth with
rich cytoplasm, round or oval nuclei. Cells exposed to
UA rounded up, lacked cell-cell contact with low density
of cell (Figure 1(b)). Furthermore, H&E staining revealedJournal of Biomedicine and Biotechnology 3
Table 1: IC50 ofUAatdiﬀerent timepointsin humangastric cancer
cell BGC-803.
IC50 (uM) X2 P Probit
12h 61.29 0.005 1.0 7.60-13.5x
24h 43.78 0.027 1.0 5.49-9.01x
36h 35.94 0.07 0.99 3.08-4.79x
48h 24.95 0.018 1.0 5.74-8.08x
that cells treated with UA showed typical morphology for
apoptosis: nuclear fragmentation, chromatin condensation,
and loss of membrane asymmetry (Figure 1(c)). In addition,
fragments of degraded DNA were observed in agarose gel
electrophoresis for BGC-803 cells treated with 43.78 and
35.94μM UA.This was an indicationthat apoptosisoccurred
in the cells. For the control cells without treatment, no
fragment of DNA was observed (Figure 1(d)). We further
evaluated the apoptotic rate by Annexin-V staining. BGC-
803 cells treated with UA had more apoptotic cells than
cells treated with DMSO or without treatment (F = 72.579,
P<. 01,Figures 1(e)and 1(f)),while there was no signiﬁcant
diﬀerence in apoptosis between cells treated with DMSO or
without treatment indicating that apoptosis was speciﬁcally
induced by UA treatment.
We investigated the mechanism how UA induced apop-
tosis. Expression of Pro caspase-3, -8, and -9, Bcl-2, Bax was
detected by Western blot (Figure 1(g)). Relative amount of
protein was calculated (Figure 1(h)). Our data showed that
expression of pro caspase-3, -8, and -9 protein declined after
UA treatment (P<. 05), indicating that activated caspase-3,
-8, -9 proteins were induced by UA treatment. Expression of
Bcl-2 protein was downregulated by UA treatment (P<. 05),
while Bax proteinexpression did not show signiﬁcant change
with and without UA treatment. Our result suggested that
UA may activate caspase cascade and downregulate Bcl-2
protein to induce apoptosis in gastric cancer cell line BGC-
803.
3.3. Inhibition of Tumor Growth in Mouse Xenograft Model.
Compared tonegative control,xenograftswhich were treated
with UA were robust and had more weight (Table 2). There
was 52.8% inhibition rate of tumor growth in UA treatment
xenografts. Tumor tissue was examined underoptical micro-
scope after H&E staining. Tumor cells in negative control
resembled nests or cords and showed vigorous mitosis.
Nuclei of tumor cells were round or oval; while there was
more necrosis and apoptosis in UA treatment group, density
of tumor cells decreased. We examined the proliferation of
tumorcellsinxenograftsbyPET-CT. Xenograftswasinjected
with 18F-FLT, and the whole mouse was imaged by PET-
CT. Focal 18F-FLT uptake could be observed in tumor and
abdominal cavity in xenografts of PS control (Figure 2(a)
upper panel). Xenografts with UA treatment showed lower
18F-FLT uptake in tumor (Figure 2(a) lower panel). The
imageofPET-CT showed directlythat proliferationoftumor
cells declined by UA treatment in vivo. To elucidate the
mechanism how UA inhibited proliferation of tumor cells,
we examined cell cycle of these tumor cells in xenografts.
Percentange of 38.71±3.27ofthetumorcellstreatedwithUA
were in G0/G1 stage(P<. 05,Figure2(b)),but48.97±3.96%
and 23.53 ± 5.97% cells were in S or G2/M stage for the
negative control, suggesting that UA treatment decreased
proliferation of tumor cells in mouse xenograft model.
3.4. Induction of Apoptosis in Mouse Xenograft Model. In ad-
dition to cell cycle, we also examined the apoptosis of tumor
cells in xenografts. Tumor cells in xenografts treated with
UA had more apoptosis as shown in Figure 2(b) (sub-
G1). The apoptotic tumor cells were quantiﬁed by ﬂow
cytometry after cells were incubated with FITC conjugated
Annexin-V. Comparison of apoptotic rate of the PS control
to the UA treatment group revealed statistically signiﬁcant
diﬀerent (12.91 ± 1.43 for PS control versus 37.24 ± 3.85
for UA treatment, P<. 05, Figure 2(c)), indicating that
UA treatment could induce apoptosis of tumor cells in
mouse xenograft model. Furthermore, we examined the
expression of Caspase-3, -8 in these tumor cells. The result
of western blot showed that the protein level of Caspase-
3, -8 was elevated after treatment with UA (Figure 2(d)).
Our data suggested that UA may induce apoptosis through
upregulation of Caspase-3 and 8.
4.Discussion
UA is one anticancer active compound in Chinese anticancer
herbal medicines. Previous studies showed that UA could
inhibitgrowthofcoloncancercells, endometrialcancercells,
and melanoma cells [11–13]. It has been reported that UA
inhibited growth of tumor cells through multiple functions,
such as cytotoxicity [14, 15], induction of apoptosis [9, 10,
16, 17], and prevention of angiogenesis [18, 19].
Our results showed that UA decreased proliferation of
tumor cells both in vitro and in vivo. UA inhibited prolifera-
tionofBGC-803cellsin dose-and time-dependentmanners.
Inhibition rate of tumor growth is 52.8% in H22 xenografts
treated with UA. Cell cycle of tumor cells from xenagrafts
treated with UA was arrested in G0/G1 stage. Our data
are consistent with the results of lung cancer cell A549
treated with UA [20], Hsu showed that UA up-regulated P21
expression through a P53-dependent manner and decreased
expression of cyclins and their activating partner cdks. UA
may block cell cycle progression in G0/G1 stage in gastric
cancer cell and tumor cells from xenografts by activat-
ing P53/P21 pathway concomitant with inactivating cy-
clins/cdks.
Mammalian cell apoptosis is initiated either by mito-
chondria-mediated or Fas receptor coupled extrinsic signals
mediated pathways. Many apoptotic-related genes involved
in these processes, including proapoptotic genes (Bax, Bid,
and Bak), antiapoptotic genes (Bcl-Xl and Bcl-2), and cys-
teine proteases called caspases (caspase-3, -8, and -9). Bcl-
2 family plays an important role in preventing apoptosis.
The ratio of Bax to Bcl-2 can be used to assess apoptosis.
The higher this ratio is, the more possibility apoptosis would
h a p p e n ,a n dv i c ev e r s a .W ef o u n dt h a tt h ee x p r e s s i o no f
Bcl-2 protein decreased, but the level of Bax protein did4 Journal of Biomedicine and Biotechnology
Control
0.2%DMSO
10mM UA
30mM UA
20mM UA
40mM UA
50mM UA
60mM UA
Error bars: +/−2S E
Time (h)
T
h
e
O
D
v
a
l
u
e
a
t
4
9
2
/
6
3
0
n
m
(
m
e
a
n
)
12 24 36 48
0
0.2
0.4
0.6
0.8
(a)
Control 24h UA 24h
(b)
UA 24h Control 24h
(c)
2000
1000
750
500
250
100
(bp)
U
A
3
6
h
I
C
5
0
U
A
2
4
h
I
C
5
0
0
.
2
%
D
M
S
O
C
o
n
t
r
o
l
M
a
r
k
e
r
(d)
Figure 1: Continued.Journal of Biomedicine and Biotechnology 5
Annexin-V
P
r
o
p
i
d
i
u
m
i
o
d
i
d
e
100
101
102
103
104
100 101 102 103 104
Annexin-V
P
r
o
p
i
d
i
u
m
i
o
d
i
d
e
100
101
102
103
104
100 101 102 103 104
Annexin-V
P
r
o
p
i
d
i
u
m
i
o
d
i
d
e
100
101
102
103
104
100 101 102 103 104
Con DMSO UA
(e)
Con DMSO UA
Error bars: +/−2E S
A
p
o
p
t
o
t
i
c
r
a
t
e
(
%
)
0
0.5
1
1.5
2 ∗
(f)
Procaspase-3
Procaspase-9
Procaspase-8
Bcl-2
Bax
β-actin
32
45
56
29
22
43
(
k
D
a
)
Control DMSO UA
(g)
UA
DMSO
Control
∗P<. 05
∗
∗
∗
∗
Error bars: +/−2E S
R
a
t
i
o
o
f
O
D
(
m
e
a
n
)
0
0.1
0.2
0.3
0.4
0.5
P
r
o
c
a
s
p
a
s
e
-
3
P
r
o
c
a
s
p
a
s
e
-
9
P
r
o
c
a
s
p
a
s
e
-
8
B
c
l
-
2
B
a
x
(h)
Figure 1: UA inhibited proliferation and induced apoptosis in gastric cancer cell BGC-803. (a) Inhibition of proliferation of BGC-803 was
assessed by MMT staining. (b) Morphological changes of BGC-803 cells after UA (IC50 (24h)) treatment for 24h (Bar represents 200μm);
magniﬁed image of cells was showed in corner (Bar represents 200μm). (c) H&E staining of BGC-803 cells after UA (IC50 (24h)) treatment
for 24h (Bar represents 200μm), and arrows indicated apoptotic cells; magniﬁed image of cells was showed in corner (Bar represents
200μm). (d) DNA ladder was found in BGC-803 cells treated with UA (IC50 (24h) and IC50 (36h)), not in BGC-803 cells treated with
0.2% DMSO or without treatment. (e) Apoptosis of BGC-803 cells induced by UA was detected by Annexin-V staining and ﬂow cytometry.
(f) was the quantiﬁed data from experiment showed in (e). Apoptotic rate was 0.66 ± 0.15, 0.67 ± 0.08, and 1.69 ± 0.11 in control, DMSO,
and UA treated cells, respectively, (∗P<. 01). (g) Western blot showed expression of apoptotic related genes in BGC-803 cell treated with
DMSO, UA and without treatment; β-actin was used as internal control. (h) showed related amount of protein from (g) (∗P<. 05).6 Journal of Biomedicine and Biotechnology
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Figure 2: UA inhibited proliferation and induced apoptosis in hepatocellular carcinoma cell H22 mouse xenograft. (a) Xenografts treated
with PS or UA were imaged by PET-CT. (b) Cell cycle of tumor cells from xenografts treated with PS or UA was examined. Cell cycle
distribution was showed in the table (∗P<. 05). (c) Apoptosis of tumor cells from xenografts induced by UA was detected by Annexin-V
staining and ﬂow cytometry. Quantiﬁed data showed in the table below (∗P<. 05). (d) Western blot showed expression of Caspase-3 and
Caspase-8 in tumor cells from xenografts treated with PS or UA.
Table 2: Weight of xenografts treated with PS or UA.
Day 1 Day 3 Day 5 Day 7 Day 9 Day 11
PS control (g) 22.04 ± 0.73 23.93 ±0.83 25.41 ±0.65 27.46 ±1.35 29.51 ±1.47 30.05 ±1.51
UA treatment (g) 21.88 ± 0.57 24.85 ±0.53 27.17 ±0.89 29.39 ±1.62 31.66 ±2.43 32.68 ±2.65
not change in BGC-803 cells treated with UA. The ratio
of Bax/Bcl-2 increased, which would lead to apoptosis.
Previous studies showed that Bax expression increased and
Bcl-2 expression decreased in lung cancer cell line A549
treated with UA [20]. Expression of Bax protein signiﬁcantly
increased in human breast cancer cell line MCF-7 [21]. The
results above are diﬀerent from ours, suggesting that UA
may function diﬀerently in diﬀerent type of cancer cells to
induce apoptosis. Caspase-3 is a key protease in mammalian
cell apoptosis. We found that caspase-3 was activated in
BGC-803 cells and H22 cell xenograft treated with UA. It
is reported that cytochrome C was released and caspase-3
was activated in BGC-823 cells with UA treatment [22]. Our
data showed that caspase-8 and -9 were all activated in BGC-
803 cells, indicating that UA induced apoptosis through two
classical apoptotic pathways. Studies have demonstrated that
caspase-3, -8, and -9 are necessary for UA inducing tumor
cell apoptosis [23]. Our ﬁndings of decreased level of Bcl-2
with no change of Bax and activated caspase-8 and -9 in cell
line BGC-803 enrich the understanding of mechanisms how
UA induces apoptosis in gastric cancer cell line BGC-803.
Furthermore, we found expression of caspase-8 was elevated
in tumor cells obtained from H22 xenograft, indicating that
UA also can induce apoptosis in vivo.
5.Conclusions
In summary, we found that UA inhibited growth of gastric
cancer cell line BGC-803 in dose-dependent and time-
dependent manner in vitro. UA treatment arrested tumor
cells from xenograft to G0/G1 stage in vivo. The apoptotic
rate was signiﬁcantly increased in tumor cells treated with
UA both in vitro and in vivo (P<. 05). DNA fragmentation
was found in BGC-803 cells exposed to UA. UA activated
caspase-3, -8, -9 and downregulated expression of Bcl-2 in
BGC-803 cells, but had no eﬀect on expression of Bax.
Expression of caspase-3 and -8 were elevated in tumor cells
from xenograft treated with UA. UA inhibited growth of
tumor cells in vitro and vivo by decreasing proliferation and
inducing apoptosis. Understanding the mechanism of UA
will help us fully understand how Chinese medical herbs
work.
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